Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES GSK PHARMA DIVIS LABORATORIES/
GSK PHARMA
 
P/E (TTM) x 31.5 59.7 52.8% View Chart
P/BV x 8.3 9.1 92.0% View Chart
Dividend Yield % 0.8 6.3 12.9%  

Financials

 DIVIS LABORATORIES   GSK PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
GSK PHARMA
Mar-22
DIVIS LABORATORIES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs5,4251,917 283.0%   
Low Rs3,5621,400 254.4%   
Sales per share (Unadj.) Rs337.5193.5 174.4%  
Earnings per share (Unadj.) Rs111.522.5 496.2%  
Cash flow per share (Unadj.) Rs123.326.5 465.1%  
Dividends per share (Unadj.) Rs30.0090.00 33.3%  
Avg Dividend yield %0.75.4 12.3%  
Book value per share (Unadj.) Rs441.8157.2 281.1%  
Shares outstanding (eoy) m265.47169.41 156.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.38.6 155.3%   
Avg P/E ratio x40.373.8 54.6%  
P/CF ratio (eoy) x36.562.6 58.3%  
Price / Book Value ratio x10.210.6 96.4%  
Dividend payout %26.9400.4 6.7%   
Avg Mkt Cap Rs m1,192,890280,960 424.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9,4626,102 155.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,59832,780 273.3%  
Other income Rs m1,159758 153.0%   
Total revenues Rs m90,75733,538 270.6%   
Gross profit Rs m38,8117,735 501.8%  
Depreciation Rs m3,115682 456.9%   
Interest Rs m2020 100.2%   
Profit before tax Rs m36,8357,790 472.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2313,983 181.5%   
Profit after tax Rs m29,6053,808 777.5%  
Gross profit margin %43.323.6 183.6%  
Effective tax rate %19.651.1 38.4%   
Net profit margin %33.011.6 284.5%  
BALANCE SHEET DATA
Current assets Rs m96,10437,080 259.2%   
Current liabilities Rs m24,54416,984 144.5%   
Net working cap to sales %79.961.3 130.3%  
Current ratio x3.92.2 179.3%  
Inventory Days Days991 9.6%  
Debtors Days Days987229 432.1%  
Net fixed assets Rs m50,0878,121 616.8%   
Share capital Rs m5311,694 31.3%   
"Free" reserves Rs m116,75124,936 468.2%   
Net worth Rs m117,28226,630 440.4%   
Long term debt Rs m00-   
Total assets Rs m146,19145,201 323.4%  
Interest coverage x1,842.8391.3 470.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.7 84.5%   
Return on assets %20.38.5 239.3%  
Return on equity %25.214.3 176.5%  
Return on capital %31.429.3 107.1%  
Exports to sales %00-   
Imports to sales %19.727.0 73.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,6768,853 199.7%   
Fx inflow Rs m78,445528 14,863.3%   
Fx outflow Rs m17,9538,853 202.8%   
Net fx Rs m60,492-8,325 -726.6%   
CASH FLOW
From Operations Rs m19,1188,107 235.8%  
From Investments Rs m-21,949-4,055 541.3%  
From Financial Activity Rs m-5,324-5,242 101.6%  
Net Cashflow Rs m-8,156-1,190 685.3%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 36.5 12.8 285.0%  
FIIs % 16.5 2.2 764.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 25.0 192.2%  
Shareholders   346,905 112,964 307.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    


More on Divis Laboratories vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs GSK Pharma Share Price Performance

Period Divis Laboratories GSK Pharma S&P BSE HEALTHCARE
1-Day -0.25% -1.48% 0.67%
1-Month 1.64% -2.40% 1.42%
1-Year -23.22% -3.84% -10.55%
3-Year CAGR 30.32% 0.87% 23.16%
5-Year CAGR 33.89% -10.42% 11.48%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

GSK Pharma paid Rs 90.0, and its dividend payout ratio stood at 400.4%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

3 Reasons Why Sensex Rallied 1,016 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and ended near day's high.